The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

The authors caution in the report that the trial was "underpowered to provide statistically rigorous results and was thus exploratory in nature." To heartwire,Cappato said an adequately powered trial ...